4James J. Starling,Ronald S. Maciak,N. Ann Hinson,Cynthia L. Nichols,Stephen L. Briggs,Bennett C. Laguzza. In vivo efficacy of monoclonal antibody — drug conjugates of three different subisotypes which bind the human tumor — associated antigen defined by the KS1/4 monoclonal antibody[J] 1989,Cancer Immunology Immunotherapy(3):171～178 被引量：1
5Richard L. Wahl,Jeffrey Barrett,Onelio Geatti,Monica Liebert,Barry S. Wilson,Susan Fisher,John G. Wagner. The intraperitoneal delivery of radiolabeled monoclonal antibodies: studies on the regional delivery advantage[J] 1988,Cancer Immunology Immunotherapy(3):187～201 被引量：1
6Léontine Dazord,Dominique Bourel,Anne Martin,Rozenn Lecorre,Patrick Bourguet,Joelle Bohy,Jean-Claude Saccavini,Philippe Delaval,Micheline Louvet,Louis Toujas. A monoclonal antibody (Po66) directed against human lung squamous cell carcinoma immunolocalization of tumour xenografts in nude mice[J] 1987,Cancer Immunology Immunotherapy(3):263～268 被引量：1
9James J. Starling,Ronald S. Maciak,N. Ann Hinson,Cynthia L. Nichols,Stephen L. Briggs,Bennett C. Laguzza. In vivo efficacy of monoclonal antibody — drug conjugates of three different subisotypes which bind the human tumor — associated antigen defined by the KS1/4 monoclonal antibody[J] 1989,Cancer Immunology Immunotherapy(3):171～178 被引量：1
